Its not Permetrex which is the issue for other companies and FDA approval however the accuracy with dealing with the plant matter compared with what BOT is doing which is synthetic. It does have this info somewhere and definitely explains it better.
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-138
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.103M | 6.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32406 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 234417 | 5 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
